DALAVIR

DALAVIR
Product Description

Dolutegravir/Lamivudine/Tenofovir disoproxil fumarate 50/300/300 mg

Dolutegravir increases the immune cells that help fight infections in the body and decreases the amount of HIV in the blood.

WHO recommends Dolutegravir as preferred HIV treatment option in all populations
Effective antiretroviral agent for both treatment-naive and treatment-experienced patients infected with HIV

✓Good tolerability

✓Infrequent drug–drug interactions

✓Co-formulation

✓Once-daily administration

The Government Pharmaceutical Organization (GPO)

  • Country/Region:
    Thailand
  • On CPHI since:
    2015
  • Certificates:
    1
  • Employees:
    1000 - 4999
Company types
Association/Government
Pharmaceutical company
Primary activities
Pharmaceutical Company (generic finished products)
Specifications
  • Selling Points
    Convenience; Price; Product Features; Product Performance

The Government Pharmaceutical Organization (GPO)

  • Country/Region:
    Thailand
  • On CPHI since:
    2015
  • Certificates:
    1
  • Employees:
    1000 - 4999
Company types
Association/Government
Pharmaceutical company
Primary activities
Pharmaceutical Company (generic finished products)

More Products from The Government Pharmaceutical Organization (GPO) (2)

  • GPO-L-ONE

    Product GPO-L-ONE

    Deferiprone Tablet 500 mg

    Iron Chelating Agent
    For Treatment of iron overload in thalassemia patients
    Oral Iron Chelator for Good Compliance

    High Affinity for iron Binding

    Effective Removal of Excess Iron from the Body

    Provides Significant Ca...
  • TEDAVIR

    Product TEDAVIR

    Dolutegravir/Emtricitabine/Tenofovir Alafenamide Tablets 50/200/25 mg are indicated for use as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults and pediatric patients weighing at least 40 kg. In addition to being used for treatment. The product is smal...